ARID2 and cancer: When EMT biomarkers were detected in H1299 cells with cotransfection of USP2 shRNAs and ARID2 overexpression vectors, we found that in comparison with cancer cells with USP2 shRNAs transfection, the cotransfection demonstrated notably diminished tendency of mesenchymal phenotype transition (Figure 5(i)).